Clinical trial
Dupilumab Registry Study
NCT03411837 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dupilumab Registry Study
- Lead sponsor
- Northwestern University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 16, 2017
- Completion date
- August 31, 2019
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis